CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 14 March 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00368-06v1
14/5/624    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Jesus, M.
Right arrow Articles by Wheat, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Jesus, M.
Right arrow Articles by Wheat, L. J.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00368-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Galactoxylomannan does not Exhibit Cross-Reactivity in the Platelia Aspergillus EIA

Magdia De Jesus, Emily Hackett, Michelle Durkin, Patricia Connolly, Arturo Casadevall, Ruta Petraitiene, Thomas J. Walsh, and L. Joseph Wheat*

Albert Einstein College of Medicine, 1300 Morris Park Avenue, Forchheimer 411, Bronx, NY 10461; MiraVista Diagnostics, Indianapolis, IN, USA; National Cancer Institute, Pediatric Oncology Branch, Immunocompromised Host Section, CRC, Rm 1W-5750, 10 Center Drive, Bethesda, MD 20892-1100; Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, MD 21702

* To whom correspondence should be addressed. Email: jwheat{at}miravistalabs.com.


   Abstract

Given the recent report of a false-positive result in the Platelia Aspergillus EIA in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross reactions.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.